Our results reveal the importance of the GC-KLF15-BCAA axis in SMA pathogenesis and highlight its potential as a therapeutic target to attenuate muscle and metabolic disturbances in SMA. This evidence concerns the gene GC and proximal spinal muscular atrophy.